A new paradigm for personalized prophylaxis for patients with severe haemophilia A-Reference-Cited by-同舟云学术

A new paradigm for personalized prophylaxis for patients with severe haemophilia A

Published:2020-02-26 Issue:2 Volume:26 Page:228-235
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Delavenne Xavier¹^ORCID,Ollier Edouard¹,Lienhart Anne²,Dargaud Yesim²^ORCID

Affiliation:

1. Institut national de la santé et de la recherche médicale (Inserm) UMR 1059 Dysfonction Vasculaire et de l'Hémostase Université de Lyon Saint Etienne France

2. Unité d'Hémostase Clinique Hôpital Cardiologique Louis Pradel Université Lyon 1 Lyon France

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13935

Reference19 articles.

1. Haemophilia A and haemophilia B: molecular insights

2. Guidelines for the management of hemophilia

3. Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement

4. Impact of Adopting Population Pharmacokinetics for Tailoring Prophylaxis in Haemophilia A Patients: A Historically Controlled Observational Study

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B;Haemophilia;2024-04-22

2. Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B;Research and Practice in Thrombosis and Haemostasis;2024-03

3. Pharmacokinetic–Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate;European Journal of Drug Metabolism and Pharmacokinetics;2024-02-17

4. The value‐based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia;Haemophilia;2024-02-05

5. Population pharmacokinetics/toxicokinetics;Public Health and Toxicology Issues Drug Research, Volume 2;2024